Cite
MLA Citation
George Blumenschein et al.. “278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A169–A170. http://access.bl.uk/ark:/81055/vdc_100144722384.0x000004